Search

The migration flows connecting Thailand and Europe have constructed social spaces in which different stereotypes regarding Thais and Europeans emerge, perpetuate, and circulate, thereby affecting to various extents the lives of these individuals. To challenge these stereotypes, the present Special Issue takes into account the mechanisms of social categorization at transnational and local dimensions in three critical steps. First, it adopts an inclusive stance by not limiting itself to heterosexual relationships involving Thais and Europeans. Second, it shifts the scholarly gaze from marriage and family issues to Thai migrants’ mobilities in spatial, social, and intergenerational terms. And third, it highlights Thai migrants’ engagement in the labor market as intimate workers and entrepreneurs to uncover the factors shaping their (re)productive labor and social incorporation in their receiving countries. Using an intersectional approach, this Special Issue presents six empirically grounded case studies to unveil often-neglected dimensions and complexities of Europe-Thailand transnational migration.

This paper examines Thai immigrant entrepreneurship in the UK, drawing on 17 inter-views with Thai migrants in Brighton, East Sussex. It explores how Thai immigrants from different socioeconomic backgrounds and migration pathways mobilize ethnic and non-ethnic forms of capital in their entrepreneurial activities. Thai immigrants constitute a relatively new, small, but internally diverse migrant population in the UK, with female marriage migrants dominating the Thai migrant population in the past two decades. The findings of this study reveal that Thai migrants tend to own small-scale businesses or provide personal services in three sectors: cleaning and care work, beauty and massage, and food and catering. In their interaction with opportunity structures in the UK, Thai restaurant and massage entrepreneurs mobilize the exotic notion of “Thai-ness” to add value to their services catering to local British customers.

The interview with Mrs. Chongcharoen Sornkaew Grimsmann, a long-term member and former president of Thai Women Network in Europe (TWNE), was originally conducted in English over email by Sirijit Sunanta and Asuncion Fresnoza-Flot in July 2022. It was supplemented by an online interview (via WebEx) in Thai by Sirijit Sunanta in November 2022. Mrs. Grimsmann served as the President of TWNE from 2019 to 2022. TWNE is well-established and one of the most active organizations of Thai migrant women with individual and organizational members in 16 European countries, the US, and Thailand. TWNE seeks to collaborate with governmental and non-governmental organizations, both in Thailand and the destination countries, to improve the welfare of Thai migrant women. They organize annual general meetings to discuss topics relevant to Thai migrant women’s lives in destination countries and publish an annual newsletter Sarn Satree (สารสตรี) to circulate information. Mrs. Grimsmann has extensive experience of providing community service as a social volunteer and working with international organizations, particularly in the area of women and children’s welfare. She is now based in France and Thailand.

Abstract This study compared weight and cardiometabolic changes after short-term treatment of olanzapine/samidorphan and olanzapine. Eligible criteria for an included trial were ≤ 24 weeks, randomized controlled trials (RCTs) that compared olanzapine/samidorphan and olanzapine treatments in patients/healthy volunteers and reported weight or cardiometabolic outcomes. Three databases were searched on October 31, 2020. Primary outcomes included weight changes and all-cause dropout rates. Standardized mean differences (SMDs) and risk ratios (RRs) were computed and pooled using a random-effect model. This meta-analysis included four RCTs (n = 1195). The heterogeneous data revealed that weight changes were not significantly different between olanzapine/samidorphan and olanzapine groups (4 RCTs, SDM = − 0.19, 95% CI − 0.45 to 0.07, I 2 = 75%). The whole-sample, pooled RR of all-cause dropout rates (4 RCTs, RR = 1.02, 95% CI 0.84 to 1.23, I 2 = 0%) was not significant different between olanzapine/samidorphan and olanzapine groups. A lower percentage of males and a lower initial body mass index were associated with the greater effect of samidorphan in preventing olanzapine-induced weight gain. Current evidence is insufficient to support the use of samidorphan to prevent olanzapine-induced weight gain and olanzapine-induced cardiometabolic abnormalities. Samidorphan is well accepted by olanzapine-treated patients.

Abstract We compared the efficacy, safety, and acceptability of lurasidone at different doses to establish the dose–response relationships of lurasidone therapeutic and adverse effects in acute schizophrenia. Included trials were 4- to 16-week, fixed-dose, randomized controlled trials of lurasidone in adults with acute schizophrenia. Different doses of lurasidone, other antipsychotics, and placebo were considered as independent treatments. Apart from all-cause dropout rates, four therapeutic and four adverse outcomes were included in the frequentist network meta-analysis (NMA). Lurasidone 160, 120, 80, 40, and 20 mg/day were studied in ten trials of 3,366 adults with schizophrenia exacerbation. Lurasidone 160 mg/day reduced Positive and Negative Syndrome Scale (PANSS) total scores significantly more than lurasidone 120, 80, 40, and 20 mg/day (mean differences = − 7.63, − 7.04, − 8.83, and − 12.25, respectively). All-cause dropout rates were significantly lower in participants receiving lurasidone 160 mg/day and 80 mg/day compared with those taking placebo. The half-maximal effective doses of lurasidone for PANSS total, PANSS positive, and MADRS score reductions were higher than 80 mg/day. The confidence of all NMA estimates was low or very low. Lurasidone 160 mg/day is currently the most efficacious and acceptable dose for acute schizophrenia. Its maximal effective doses may be higher than 160 mg/day.

Abstract This study aimed to determine: i) the correlation between objective and subjective cognition, ii) the correlates of objective and subjective cognition and iii) the predictors of discrepancy between objective and subjective cognition. Participants were non-elderly patients with major depressive disorder (MDD). We assessed subjective cognition using the Perceived Deficit Questionnaire for Depression (PDQ-D) and objective cognition using Face I and Face II tests of the Wechsler Memory Scale, 3rd edition and Digit Span and Matrix Reasoning tests of the Wechsler Intelligence Scale for Adults, 3rd edition. The discrepancy between objective and subjective cognition was estimated. Participants were 57 outpatients with MDD. PDQ-D scores were not correlated with composite neurocognitive test (NCT) z scores. Years of education significantly predicted composite NCT z scores, as did age. The 9-item Patient Health Questionnaire (PHQ-9) scores significantly predicted PDQ-D scores, as did antidepressant treatment. Age significantly predicted discrepancy scores, as did PHQ-9 scores. In conclusion, objective and subjective cognition in patients with MDD are not correlated. Age and education predict objective cognition. Depression. severity and antidepressant treatment predict subjective cognition. Age and depression severity may predict the discrepancy between objective and subjective cognition.

Sirijit Suttajit, Sutrak PilakantaDepartment of Psychiatry, Faculty of Medicine, Chiang Mai University, Chiang Mai, ThailandBackground: Little is known about the effect of social support on nonadherence in persons with schizophrenia, especially in developing Asian countries where social support is considered to be imperative. Additionally, the role of depression as a mediator in the association between social support deficits and nonadherence has not been evaluated.Methods: This was a cross-sectional study conducted in 75 participants at a university hospital in Thailand. Logistic regression was used to determine whether depression and a deficit in social support were associated with nonadherence, and whether depression mediated this association.Results: There were strong relationships between nonadherence and major depressive episodes (odds ratio [OR] 9.5, confidence interval [CI] 2.3–38.9), living alone (OR 21.8, CI 3.5–143.0), and dissatisfaction with support from family (OR 10.0, CI 1.9–53.1). The OR of the association between social support deficits and nonadherence decreased by nearly one half after adjusting for depression.Discussion: Depression and social support deficits were significantly associated with nonadherence in persons with schizophrenia. Depression is important in mediating the association between social support deficits and nonadherence. Enhancing social support, as well as early detection and effective intervention for depression should be emphasized in interventions to improve adherence in persons with schizophrenia.Keywords: nonadherence, schizophrenia, depression, social support, antipsychotic drugs